...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

Here are some key dates for the upcoming ASCO meeting. Next week on April 17th, accepted abstract titles for the May 31 to June 4 ASCO 2019 meeting should be available. Full abstracts will be released on May 15th. Dr. Rahul Aggarwal stated at AACR last month "We plan to present these results in more detail at a future meeting." No guarantee, but there is a pretty good chance we see a Zenith ZEN-3694 mCRPC abstract at ASCO.

 

Share
New Message
Please login to post a reply